Anand Ranganathan

This paper shows that PfHSP70-3-SBD enhances PfCSP immunogenicity through cross-presentation, improving vaccine efficacy against malaria.

This study shows that degrading host p38-MAPK with NR-7h reduces parasite load in Leishmania and Plasmodium infections and enhances antiparasitic therapy when combined with Amphotericin B.

The paper identifies PfTSEN1 as a tRNA splicing endonuclease in Plasmodium falciparum and demonstrates its inhibition by TSENi, a novel anti-malarial compound.

This paper identifies prohibitins (PHBs) in Plasmodium falciparum as druggable targets, showing their mitochondrial localization and functional roles, and demonstrates that Rocaglamide inhibits parasite growth in multiple drug-resistant strains.

The paper reports a novel tRNA-derived peptide, tREP-18, with potent anti-leishmanial activity against L. donovani and PKDL isolates.